Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02154984 · ClinicalTrials.gov registry record · NA
Time Restricted Diet in Obese or Overweight Pre or Postmenopausal Participants
A NA study, sponsored by Northwestern University.
- Terminated
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT02154984: Clinical Trial NA study, sponsored by Northwestern University.
NCT02154984 is a NA study that was terminated before completion, run by Northwestern University. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02154984, a NA study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to study the relationships between obesity, hormones and menopausal status, and breast cancer. The researchers would like to study whether a type of nutritional intervention, called a time-restricted diet or tRD, is easy to maintain using a smartphone application; the researchers also want to study the effect that a tRD has on weight control, hormones, and breast tissue. A tRD is a type of diet that requires people to restrict their daily eating to a specific time frame each day. The researchers think that this might be an effective and manageable way to control weight.
Primary Outcome
Assessed by demonstrating that at least 65% of participants record dietary intake on at least 80% of study intervention days. Adherence will be assessed via a one-sample chi-squared test for proportions.
Interventions
- OTHER laboratory biomarker analysis
- BEHAVIORAL behavioral dietary intervention
- BEHAVIORAL telephone-based intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2014-07 |
| Est. Completion | 2017-02-23 |
| Phase | NA |
Why NCT02154984 stopped before completion
NCT02154984 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT02154984 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02154984 about?
NCT02154984 is a clinical study titled "Time Restricted Diet in Obese or Overweight Pre or Postmenopausal Participants". The purpose of this study is to study the relationships between obesity, hormones and menopausal status, and breast cancer. The researchers would like to study whether a type of nutritional intervention, called a time-restricted diet or tRD, is easy to maintain using a smartphone application; the re...
What is the current status of trial NCT02154984?
This trial is currently terminated. It is a NA study. The enrollment target is 45 participants. The study started on 2014-07. Estimated completion is 2017-02-23.
What interventions are being tested in trial NCT02154984?
The interventions under investigation include: laboratory biomarker analysis (OTHER), behavioral dietary intervention (BEHAVIORAL), telephone-based intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02154984?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02154984's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia